O
CELGZ

OrbiMed’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

OrbiMed’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-360,900
Closed -$2.9M – 135
2013
Q3 		$2.9M Sell
360,900
-139,100
-28% -$1.12M 0.05% 99
2013
Q2 		$3.66M Buy
+500,000
New +$3.66M 0.08% 98